This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
The Schreiner Group LP branch has been in existence since 2008. More than 80 employees now produce high-tech products for the entire North American market. The Blauvelt plant was founded by the current CEO Roland Schreiner, who at the time was head of the MediPharm business unit. Since then, it has grown, both in terms of employee numbers, sales and product diversity.
"Schreiner Group has performed very well in the U.S. over the past few years – now there is the opportunity to take the business to a new level of growth and expansion," Zumbolo stated. "I believe Schreiner Group still has great market potential in the United States. In the future, I see our potential as equaling that of the Schreiner Group business in Europe."
In the past, Zumbolo has already worked in Schreiner Group's two most important markets, Healthcare and Mobility, most recently for a major supplier in the automotive industry. He has experience in developing new markets, in acquisitions, in driving customer specifications, and in developing strong teams. For six years, he had led the Asia-Pacific business of a major U.S. company from China. "I am pleased that we were able to attract such an experienced leader for our largest international facility so quickly," said Chief Executive Officer Roland Schreiner. "With his experience and vision, Brian Zumbolo is a great asset to Schreiner Group."
